Nick Seewald, PhD
Nick Seewald, PhD
About
Research
Publications
Talks
People
Teaching
Software
Contact
Light
Dark
Automatic
Janet S. Carpenter
Latest with Nick
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women with Early Stage Breast Cancer
[Abstract] Crossover from One Aromatase Inhibitor (AI) to Another in the Exemestane and Letrozole Pharmacogenetics (ELPh) Trial
[Abstract] Associations between treatment-emergent symptoms and early discontinuation of aromatase inhibitor (AI) therapy
Cite
×